被 发 现 含 有 未 标 示 西 药 的 产 品
|
| |
| Singapore: HSA Alert: Two consumers experienced adverse effects after taking products with potent undeclared ingredients (English only) |
| |
The Health Sciences Authority (HSA) is alerting members of the public not to purchase or consume two products: Traditional Herbs Preparation XPE and FS++ Slimming Supplements By JPJ Slim. HSA tested the products and found that one contained potent medicinal ingredients, while the other contained the banned substance sibutramine. These adulterants can cause serious adverse effects in individuals.
A woman in her 60s had been taking Traditional Herbs Preparation XPE for over nine months to alleviate her joint pain. She received it from a friend who obtained it in Malaysia. The product label listed a variety of natural herbs as its ingredients and was marketed for general health. Although the consumer experienced a quick relief of her joint pain, it worsened when she stopped taking it or reduced the dose. This raised her doctor’s suspicion that the product may contain undeclared potent ingredients such as steroids or painkillers. HSA tested the product and detected six medicinal ingredients: dexamethasone (a steroid), chlorpheniramine (an antihistamine), ibuprofen (a non-steroidal anti-inflammatory drug), lovastatin (a cholesterol-lowering medicine), chloramphenicol and tetracycline (both antibiotics). Long-term unsupervised use of steroids such as dexamethasone can cause increased blood glucose levels (which may lead to diabetes), Cushing’s syndrome (characterised by a round face or ‘moon face’ appearance, and upper body central obesity with thin limbs), and other serious adverse effects.
HSA received feedback from a consumer who experienced insomnia, headache and confusion after taking FS++ Slimming Supplements By JPJ Slim. The product was purchased via a local social media platform that carried consumer testimonials on its quick slimming results. It was packaged in a bottle labelled with minimal information – “60 capsules”, “Made in Thailand” and a website link. HSA tested the product and detected sibutramine, a weight loss medicine that has been banned in Singapore since 2010 due to an increased risk of heart attack and stroke. The continued intake of this product could have led to serious health consequences such as heart problems and central nervous system disorders (e.g., psychosis and hallucinations).
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/announcements/press-release/hsaalert-xpe-fs
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Wednesday, Mar 2, 2022
Issued at HKT 14:00
|
| |
